| 0 (0%) | 05-13 14:23 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 13.56 | 1-year : | 15.59 |
| Resists | First : | 11.61 | Second : | 13.35 |
| Pivot price | 10.25  |
|||
| Supports | First : | 8.8 | Second : | 7.32 |
| MAs | MA(5) : | 9.86 |
MA(20) : | 10.82 |
| MA(100) : | 15 |
MA(250) : | 18.31 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 7.9 |
D(3) : | 8.8 |
| RSI | RSI(14): 39 |
|||
| 52-week | High : | 32.7 | Low : | 8.8 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ BBNX ] has closed above bottom band by 14.6%. Bollinger Bands are 66.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 9.85 - 9.9 | 9.9 - 9.95 |
| Low: | 9.36 - 9.42 | 9.42 - 9.48 |
| Close: | 9.71 - 9.8 | 9.8 - 9.9 |
Wed, 13 May 2026
Insulet - An Opportune Time To Get Involved (NASDAQ:PODD) - Seeking Alpha
Tue, 12 May 2026
BBNX: Mint patch pump launch set for end of 2027, with pharmacy channel driving growth - TradingView
Tue, 12 May 2026
Farallon and Zone Holdings disclose ownership in Beta Bionics (BBNX) — 13G/A - Stock Titan
Tue, 12 May 2026
Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation - Yahoo Finance
Mon, 11 May 2026
Number of shareholders of Beta Bionics, Inc. – NASDAQ:BBNX - TradingView
Fri, 08 May 2026
Liquidity Mapping Around (BBNX) Price Events - Stock Traders Daily
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 45 (M) |
| Shares Float | 24 (M) |
| Held by Insiders | 0.9 (%) |
| Held by Institutions | 110.8 (%) |
| Shares Short | 7,140 (K) |
| Shares Short P.Month | 7,010 (K) |
| EPS | -1.38 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.09 |
| Profit Margin | -60.3 % |
| Operating Margin | -87.9 % |
| Return on Assets (ttm) | -15.1 % |
| Return on Equity (ttm) | -22.8 % |
| Qtrly Rev. Growth | 56.5 % |
| Gross Profit (p.s.) | 1.41 |
| Sales Per Share | 2.47 |
| EBITDA (p.s.) | -1.7 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -55 (M) |
| Levered Free Cash Flow | -44 (M) |
| PE Ratio | -6.96 |
| PEG Ratio | 0 |
| Price to Book value | 1.56 |
| Price to Sales | 3.85 |
| Price to Cash Flow | -7.75 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|